Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 01, 2018 9:03am

43 Views

Post# 28906769

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:135 million shares and counting

Excellent. Thank you. Should not be too difficult to do animal testing???? Maybe?

------------------------------------------------------------------------------------------------------------------------------------

They would need at a minimum dosing and toxicity levels, which is different than what they are doing now (locally). The fact that TLD has been well tolerated locally helps, but there probably still needs to be more work done in animal models for systematic dosing

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains